Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Tumor Progression02:07

Tumor Progression

3.1K
3.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.7K
5.7K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep spatial sequencing revealing differential immune responses in human hepatocellular carcinoma.

Frontiers in cell and developmental biology·2025
Same author

Deep Spatial Sequencing Revealing Differential Immune Responses in Human Hepatocellular Carcinoma.

bioRxiv : the preprint server for biology·2025
Same author

Utility analyses of AVITI sequencing chemistry.

BMC genomics·2024
Same author

Utility Analyses of AVITI Sequencing Chemistry.

bioRxiv : the preprint server for biology·2024
Same author

Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing.

Hepatology communications·2024
Same author

Long-read single-cell sequencing reveals expressions of hypermutation clusters of isoforms in human liver cancer cells.

eLife·2024

Related Experiment Video

Updated: Apr 23, 2026

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.1K

Novel fusion transcripts associate with progressive prostate cancer.

Yan P Yu, Ying Ding, Zhanghui Chen

    The American Journal of Pathology
    |September 21, 2014
    PubMed
    Summary

    Novel fusion transcripts in prostate cancer (PCa) correlate with aggressive disease. Identifying these genetic alterations can predict recurrence and metastasis, improving patient outcomes after treatment.

    More Related Videos

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    10.3K
    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    5.8K

    Related Experiment Videos

    Last Updated: Apr 23, 2026

    Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
    09:49

    Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

    Published on: July 5, 2019

    9.1K
    miRNA Expression Analyses in Prostate Cancer Clinical Tissues
    11:29

    miRNA Expression Analyses in Prostate Cancer Clinical Tissues

    Published on: September 8, 2015

    10.3K
    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
    12:13

    Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

    Published on: November 19, 2019

    5.8K

    Area of Science:

    • Oncology
    • Genomics
    • Molecular Biology

    Background:

    • The molecular mechanisms driving aggressive prostate cancer (PCa) behavior are not fully understood.
    • Identifying biomarkers for PCa progression is crucial for effective patient management.

    Purpose of the Study:

    • To discover and validate novel fusion transcripts in PCa.
    • To investigate the association between these fusion transcripts and PCa aggressiveness and recurrence.

    Main Methods:

    • Whole genome and transcriptome sequencing of PCa and matched normal tissues.
    • Validation of identified fusion transcripts using multiple methods.
    • Analysis of fusion transcript prevalence in a large cohort of PCa patients with long-term clinical follow-up.

    Main Results:

    • Discovery of novel fusion transcripts in PCa, with eight validated.
    • High prevalence (91%) of these fusion transcripts in patients experiencing PCa recurrence, metastasis, or death.
    • Fusion transcripts were significantly associated with poorer clinical outcomes compared to their absence.
    • Three specific fusion transcripts were exclusively found in recurrent or fatal PCa cases.
    • Combining fusion transcripts with Gleason's grading or nomograms improved PCa recurrence prediction.

    Conclusions:

    • Novel fusion transcripts are potential drivers of aggressive prostate cancer.
    • These fusion transcripts serve as significant biomarkers for predicting PCa recurrence and metastasis.
    • Fusion transcript analysis can enhance current prognostic models for prostate cancer.